Imago BioSciences, Inc. (IMGO), relating to its proposed merger with a subsidiary of Merck & Co. Under the terms of the tender offer, IMGO shareholders will receive $36.00 in cash per share they own.
Imago BioSciences, Inc. (IMGO), relating to its proposed merger with a subsidiary of Merck & Co. Under the terms of the tender offer, IMGO shareholders will receive $36.00 in cash per share they own.